Amgen India, the India arm of US-based biotechnology company Amgen, has announced plans to establish a new Science & Innovation Center at Genome Valley, Hyderabad, in 2027. The centre will expand Amgen's global research capabilities by integrating scientific capabilities with data and digital innovation to support the discovery and development of medicines. An MoU was signed between Amgen India and the Government of Telangana in the presence of D. Sridhar Babu, Minister for IT, Electronics & Communications, Industries & Commerce and Legislative Affairs. The documents were exchanged by Naveen Gullapalli, Managing Director, Amgen India, and Krishna Aditya, Special Secretary, Industries, Government of Telangana.
10 Less than a minute


